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Abstract
The application of nanoparticles (NPs) within medicine is of great interest; their innate
physicochemical characteristics provide the potential to enhance current technology, diagnostics
and therapeutics. Recently a number of NP-based diagnostic and therapeutic agents have been
developed for treatment of various diseases, where judicious surface functionalization is
exploited to increase efﬁcacy of administered therapeutic dose. However, quantiﬁcation of
heterogeneity associated with absolute dose of a nanotherapeutic (NP number), how this is
trafﬁcked across biological barriers has proven difﬁcult to achieve. The main issue being the
quantitative assessment of NP number at the spatial scale of the individual NP, data which is
essential for the continued growth and development of the next generation of nanotherapeutics.
Recent advances in sample preparation and the imaging ﬁdelity of transmission electron
microscopy (TEM) platforms provide information at the required spatial scale, where individual
NPs can be individually identiﬁed. High spatial resolution however reduces the sample
frequency and as a result dynamic biological features or processes become opaque. However, the
combination of TEM data with appropriate probabilistic models provide a means to extract
biophysical information that imaging alone cannot. Previously, we demonstrated that limited cell
sampling via TEM can be statistically coupled to large population ﬂow cytometry measurements
to quantify exact NP dose. Here we extended this concept to link TEM measurements of NP
agglomerates in cell culture media to that encapsulated within vesicles in human osteosarcoma
cells. By construction and validation of a data-driven transfer function, we are able to investigate
the dynamic properties of NP agglomeration through endocytosis. In particular, we statistically
predict how NP agglomerates may traverse a biological barrier, detailing inter-agglomerate
merging events providing the basis for predictive modelling of nanopharmacology.
Keywords: nanoparticle, nonhomogeneous Poisson process, transmission electron microscopy,
nanotherapeutic
(Some ﬁgures may appear in colour only in the online journal)
Introduction
The application of nanoparticles (NPs) within medicine is of
great interest; their innate physicochemical characteristics
provide the potential to enhance current technology, diag-
nostics and therapeutics. In recent years a number of NP-
based diagnostic and therapeutic agents have been developed
for treatment of various cancers, where surface functionality
has been exploited to provide more effective routes to
administration of therapeutic dose [1, 2]. As delivery systems
NPs provide an improved means to detect abnormalities at the
molecular scale; surface functionality providing increased
targeting efﬁciency and controlled release of therapeutic dose
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over a user-deﬁned period; a thorough review is provided by
Zhang et al [3]. Additionally, NPs have improved the sensi-
tivity and speciﬁcity of many imaging platforms. In parti-
cular, superparamagnetic NPs now play a key role in
magnetic resonance imaging, providing enhanced image
contrast and increased resolution to inform and quantify many
tissue abnormalities (see Na et al [4] for examples).
Despite success in these areas, application of NP tech-
nology or quantiﬁcation of NP dose at the individual cellular-
level is still at an infant stage. Speciﬁcally, detailing the
inﬂuence that the myriad of biophysical processes have on NP
agglomeration, transport within biological media, cellular
uptake, internalization and redistribution has proven difﬁcult
to quantify. This shortcoming is directly related to the
inability of high-throughput time-lapse systems to provide
rigorous cytometric measurement and analyses of the evolu-
tion path of NPs on an appropriate spatial scale (i.e. the
individual NP (nm)). If NP-based medicine is to be truly
realized in future years it is an absolute that the community
are able to accurately (i) quantify the internalized nanoma-
terial dose as opposed to that simply applied [5, 6], (ii)
determine the biological consequences associated with this
actual dose and (iii) predict how the dose evolves over time.
Electron microscopy, in particular transmission electron
microscopy (TEM), is a technical platform that can deliver
information at the required spatial scale, where individual
NPs can be identiﬁed, in terms of both number and spatial
location [7]. Recent in vitro studies have detailed the impact
of gold NP agglomeration on several cell lines [8, 9], where
this is important because comparisons of NP agglomerate size
measured in water and cell culture media report increases in
size for the latter [10]. We have previously demonstrated a
method in which NP dispersion can be rapidly frozen and
imaged in the TEM, with representative agglomerate dimen-
sions measured [11]. This provides more precise imaging of
actual NP agglomerate state in which a NP agglomerate size
and distribution is more accurately determined, a fundamental
criterion for the continued development of a nanomedicine.
TEM has also been applied to study the cellular uptake of NPs
to human mammary cells by endocytosis, with outputs sug-
gesting initial sequestration in early endosomes followed by
translocation to late endosomes or lysosomes [12]. In addi-
tion, Krpetic et al have previously used TEM to track the
intracellular distribution of peptide modiﬁed gold NPs at
several time points, covering initial membrane bound
encapsulation and release, and through to clearing of the
particles from the analyzed cells [13].
Application of this technology however comes with an
intrinsic compromise that limits temporal sampling when
compared to ﬂow cytometry and current optical microscopy
platforms. Due to reduced temporal sampling many electron
microscopy contributions to research in nanomedicine are
purely qualitative, however, there is a growing research
community that are developing novel methodologies that
provide quantitative biophysical insight of contiguous TEM
measurements [14–16]. Speciﬁcally, utilizing TEM in con-
junction with appropriate stochastic or statistical methods that
provide a bridge between measurement points can be
exploited to provide unresolvable information of the under-
lying biophysical processes in this interval.
In this work, we apply the concept of statistical analysis
to link distinct spatiotemporal TEM measurements [15] to
investigate the transport of NP agglomerates in cell culture
media, to that within endosome compartments in human
osteosarcoma cells (U2-OS cell-line). The NPs employed are
QTracker 705 nm CdTe/ZnS quantum dots at a 10 nM dose;
we have signiﬁcant experience incorporating these NPs
within U2-OS cellular systems and have demonstrated that
they are toxicologically and pharmacodynamically inert at
this dosage [17, 18], and that they may be utilized to extract
meaningful biological parameters, see [15, 17, 19–24] for
examples. QTracker 705 nm quantum dots are speciﬁcally
targeted for endocytic uptake; the NPs have an organic
coating, composed of arginine-rich targeting peptides con-
jugated to biotin bonded to streptavidin and the arginine-rich
peptides can lead to cellular uptake via micropinocytosis [25].
We image and characterize 500 distinct NP agglomer-
ates/aggregates in culture media and within endosome com-
partment cells respectively, the latter following the 1 h
exposure to the NP rich culture media. For clarity, we refer to
NP clusters in culture media as agglomerates and those within
endosomes as aggregates. Each of the NP agglomerates/
aggregates imaged via TEM is randomly selected, in the latter
case we ﬁrst randomly select 100 distinct cells from a cellular
population comprising of >104 cells and subsequently select
stochastically 500 endosomes from within this cellular sub-
population. In both spatiotemporal cases the number of
individual NPs per agglomerate/aggregate is determined [11].
Previously, we have shown stochastic sampling of high-
resolution low frequency TEM images in this manner is
capable of capturing cellular heterogeneity in NP uptake and
further redistribution within daughter cells through mitosis.
Speciﬁcally, we demonstrated that stochastic sampling of
probability mass functions (PMFs) that encapsulate NP
number per endosome and NP aggregate number per cell can
be utilized to provide the total quantum dot ﬂuorescent
intensity per cell for 104 in-silico cells. It was established that
the in-silico population accurately recreated and predicted
corresponding high-throughput ﬂow cytometry measure-
ments [15].
Analyzing the collected TEM images we construct the
PMFs that encapsulate system heterogeneity associated with
NP agglomerates/aggregates size (i.e. number of constituent
NPs) in culture media and in endosome compartments fol-
lowing 1 h NP exposure.
We demonstrate that transition of states between the two
PMFs can be achieved by considering the combined bio-
physical processes of NP transport [26] and cellular uptake as
a nonhomogeneous Poisson process (NHPP), where the rate
parameter that describes NP agglomerate aggregation at the
cellular surface or during endocytosis is driven by actual
TEM measurements. Statistical sampling of the NHPP returns
the number of NP agglomerates from within the culture media
that have attached to an active endocytic domain on the cell
surface and have subsequently been encapsulated within an
2
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endosome through one of the many endocytic pathways. The
PMF of the number of NPs per in-silico endosome is then
deduced and compared with the correspond PMF actually
measured via TEM; through difference minimization we are
able to recover the average lifetime of an active endocytic
event and the mean area of the domain and show these are
commensurate with direct measurements of clathrin-coated
pits through high-resolution optical microscopy techniques
[27, 28], validating the applicability of the methodology. This
data-driven methodology provides a means to intrinsically
embed internalized nanomaterial dose within the in-silico
endosome population [5, 6] and statistically establish how the
cell media NP dose has translated across the biological
membrane into endosome compartments in so doing addres-
sing important unmet requirements of associated with quan-
tiﬁcation of nanotheraputics.
Materials and methods
TEM
TEM was conducted on an FEI Tecnai F20 FEG-TEM
operated at 200 kV and equipped with a Gatan Orius SC600A
CCD camera. Commercially available targeted nanocrystals,
QTracker705 quantum dots dispersed at 10 nM in McCoys
5A cell culture media containing 10% fetal calf serum were
examined using the plunge-freeze method previously reported
[11]. Brieﬂy, this involves rapidly freezing a blotted 3.5 μL
droplet of the suspension on a glow discharge treated carbon
support ﬁlm in to liquid ethane. Following this, the sample
was warmed to room temperature using a rotary pumped
vacuum desiccator. In cell uptake experiments, U2OS cells
maintained in McCoys 5a media and 10% fetal calf serum at
37 °C in an atmosphere of 5% CO2 were loaded with the
commercially available targeted nanocrystals, QTracker705 at
a 10 nM concentration [15, 17]. Samples were prepared for
TEM in a standard manner [11, 15] with no additional heavy
metal stain added to the resulting 100 nm thick sections.
NP agglomerate—translation from cell culture media to
endosome compartment
In the following we present an overview of NP particle tra-
verse from media to endosome compartment. We describe
qualitatively the key biophysical states (i) NPs are loaded into
culture media (outside the cell) at the start of the experiment,
(ii) during the experiment, NPs are transported through the
media to the cell surface and may be internalized through an
active endocytic pathway and (iii) 1 h post NP load, the cel-
lular population are biologically ﬁxed and no further NP
particle internalization by the cells takes place. Time points (i)
and (iii) coincide with previously reported TEM measure-
ments of NP agglomerates in media [11] and in cellular
vesicles [15]; 500 agglomerates were imaged at random and
the number of individual NPs per agglomerate, x, was
deduced via a bespoke image analysis routine [11]. The data
Figure 1. Schematic illustrating the processes of nanoparticle sedimentation and cellular uptake over a 1 h period. (a) 0 h—NP agglomerate
are introduced to the cell media; (previously measured NP agglomerate variability is represented by black disks of varying diameter, an
example of a bright ﬁeld TEM image of a NP agglomerate in media is shown on the RHS—scale bar 75 nm) [11]. (b) Biological process—we
observe the random uptake [24] of NP agglomerates into discrete cellular vesicles, dashed red circles illustrate an endoctyic active region on
the surface of the cell that are undergoing internalization. (c) 1 h post nanoparticle load; previously distinct NP agglomerates are internalized
as aggregates through an endocytic pathway, the agglomerates are now merged into single discrete aggregate within the endosome (red
circles, an example of a TEM image of a NP agglomerate within a cellular endosome is shown on the RHS—scale bar 100 nm).
3
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measured at these distinct time points are embedded within
our model, intrinsically incorporating system heterogeneity.
Figure 1(a) is a schematic of the experimental set-up at
the beginning of the experiment (0–h) and illustrates a cellular
population (grey protuberances) in media subject to a NP dose
of 10 nM [11, 15]. Hondow et al [11] previously reported that
QTracker 705 NPs agglomerate indiscriminately in culture
media, (see results) the high heterogeneity of x is illustrated
here by the variance associated with the radii of the black
disks. A TEM image of a NP agglomerate captured in media
[11] is shown on the right-hand side of the ﬁgure (scale bar is
75 nm). During the 1 h interval of the experiment NP
agglomerates are transported to the cell surface via diffusion
and sedimentation processes. The mean transport rates of the
differently sized NP agglomerates, γ x( ), can be accurately
determined through application of the in vitro sedimentation,
diffusion and dosimetry (ISDD) model [26] speciﬁc to the NP
and experimental set-up considered.
At the cell surface NP agglomerates can be captured by
one of the many endocytic pathways and subsequently be
internalized by the cell into discrete endosome compartments
[29]. A simpliﬁed view of this complex biophysical process is
shown in ﬁgure 1(b). The ﬁgure displays a plan view of the
cellular population; cells are represented by the grey domains,
blue circles are corresponding cell nuclei and the red-dashed
circles represent areas on the cell surface where an endocytic
event is taking place. We deﬁne such to areas to be endosome
active domains (EADs). The red and black disks in the ﬁgure
represent NP agglomerates inside or outside these domains
respectively. For simplicity, we assume (i) that NP agglom-
erate attachment to receptors within individual EAD are
irreversible and all attached agglomerates are subsequently
aggregated and internalized by the cell (red) and (ii) over the
duration of the experiment EADs appear randomly (spatio-
temporally) on the cell surface and persist for a mean lifetime,
τ, where τ ≪   1 h [27]. The latter criterion together with the
approximation that NP agglomerate transport to the cell is
deduced via a mean rate over the duration of the entire
experiment, suggests that the number of distinct NP
agglomerates that impinge on a given EAD, N x( ), is intrin-
sically variable. We postulate that the variability of N x( ) is
well described if we consider the combined biophysical
processes of NP agglomerate transport and EAD attachment
as an arrival event within a NHPP. The number of random
arrivals of agglomerate with x constituent NPs is then given
by:
λ=
λ
N x
x
x
( )
( ) e
!
, (1)
x x( )
where the magnitude of rate parameter λ x( ) comprises two
principle components:
λ α=x x E x( ) ( ) ( ). (2)
The ﬁrst component α x( ) is driven by the experimental
system under investigation and is further split into the fol-
lowing expression:
α γ τ=x N x( ) ( ) , (3)EAD
where NEAD is the mean number of NPs that settle on a EAD
over the period τ (see below for calculation of N ).EAD As
outlined above γ x( ) is the deterministic rate at which a NP
agglomerate is transported to the surface of the cell during the
course of the experiment (see ISDD model below). The mean
lifetime or turnover rate an endocytic event τ, is the implicit
ﬁtting parameter of this methodology; the consequences of τ
variability is addressed and discussed in the results section of
the manuscript. The second component E x( ) is a numerical
weighting coefﬁcient, it is the product of the PMF associated
with the number of individual NPs per agglomerate measured
in media (P x( ),M see results) and the experimentally
determined range of x itself:
=E x P x x( ) ( ). . (4)M
This parameter is paramount in our data-driven metho-
dology, its magnitude is prescribed by previously measured
data, which both limits and biases the values of N x( )
accordingly via application of equation (1) (random sampling
of the NHPP). Together equations (1)–(4) provide a data-
driven and biophysically viable methodology to estimate the
number of NP agglomerates per EAD, N x( ), over the course
of its lifetime τ. Finally, ﬁgure 1(c) is a schematic of the
experimental set-up at the end of the experiment (1 h); the
diagram indicates that previously distinct NP agglomerates
within an individual EAD have been condensed into a single
aggregate through the internalization process (red ellipses);
where total NP number is conserved. A TEM image of a NP
aggregate within an endosome is shown on the right-hand
side of the ﬁgure (scale bar is 100 nm). The total number of
NPs per endosome is simply deduced via the summation:
∑=N N x x( ) . (5)E
x
Using equation (5) we can stochastically generate cor-
responding data to that measured experimentally. Speciﬁcally,
we can calculate NE for 500 simulated endosomes and
determine their corresponding probability mass distribution to
compare with that deduced experimentally within endosome
compartments 1 h post NP load.
In vitro ISDD model
The ISDD model was used to calculate the transport rates of
QTracker 705 CdTe/ZnS quantum dot agglomerates in the
cell culture media in [11]. A comprehensive review of the
equations governing particle diffusion and sedimentation are
provided by Hinderliter et al [26], furthermore the paper
provides a MATLAB script to solve the various equations and
numerous applications of the model. We modiﬁed the ISDD
model parameters to make the solution speciﬁc for QTracker
705 (CdTe) quantum dots and the biological assay used; all
parameters used are displayed in table 1.
The ISDD model provides an estimation of the diffusion
and sedimentation rates as a function of number of NPs per
agglomerate for a media depth of 287 μm over the 1 h period
of the experiment; these are displayed in ﬁgure 2, blue line
with ‘x’ markers and green line with circle markers
4
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respectively. The solid black curve in ﬁgure 3 is the mean
agglomerate transport rate as a function of the number of NPs
per agglomerate, γ x( ), which is an average of these two
processes and is employed within equation (3) to estimate the
number of NPs per agglomerate dependent, Poisson dis-
tributed, integer multiplier in equations (1) and (5). The ISDD
calculation predicts that γ x( ) is a minimum for x ~ 100 NPs
per agglomerate; that is agglomerates of this size are the
slowest to reach the cell surface; above and below this value
transport is dominated by sedimentation and diffusion
respectively.
Calculation of the mean number of NPs per endocytic active
domain NEAD
From the experimental parameters given in table 1 we can
estimate NAER from the following expression:
= ×N N A
A
, (6)f
f
EAD
EAD
here Nf is the number of NPs in the culture ﬂask, A f is the
area of the culture ﬂask and AEAD is the mean area of an
EAD. The magnitude of Nf is calculated via the expression:
= × ×N N N V ,f A c M where NA is Avogadro’s constant [22].
The latter parameter is determined empirically; the major axis
length of the 500 endosome sample was quantiﬁed through
image based analysis, the mean, standard deviation and the
lower and higher extremities were determined to be 213, 102,
62 and 497 nm respectively. There magnitudes are congruent
with that measured through stochastic optical reconstruction
microscopy [30]. We approximate the EAD capture area in
our simulations to be circular given by π=A REEAD 2.
Results
Figure 3(a) plots the PMFs corresponding to the experimen-
tally determined number of NPs per agglomerate, x [11, 15].
The PMF of x measured at 0-h in media, P x( ),M is the black
curve with circle markers, the PMF corresponding to the
number NPs per endosome measured after 1 h, P x( ),E is the
red curve with square markers. In both experimental cases,
500 randomly selected NP agglomerates/aggregates were
selected and imaged via TEM, the number of distinct NPs
within each cluster was determined via image analysis rou-
tines run on MATLAB [11].
To capture the observed variability associated with x,
both curves in ﬁgure 3(a) are plotted on a semi-log x-axis. In
media, x varies over the interval 1 to ~800 NPs; TEM images
in ﬁgures 2(b) and (c), show examples from within the range,
where the centroid positions of each individual NP within the
agglomerate (red dots) is also shown [11]. Similarly,
ﬁgures 2(d) and (e) display TEM images of low and high NP
aggregate densities (17 and 320 NPs respectively) within
endosome compartments, where x now spans the extended
interval 1 to ~1500 NPs. Comparing P x( )M and P x( ),E it is
evident that the most probable magnitude of x has increased
by two orders of magnitude (from 1 to 546 NPs), suggesting
an accumulation of distinct NP agglomerates occurs during
the endocytic process. Accumulation of NP agglomerates can
take place at the cell surface within the lifetime of the EAD or
may occur between early endosomes post internalization. In
our methodology the exact biophysical mechanism(s) cannot
be identiﬁed, but we have conﬁdence that they have occurred
due to the observed positive shift shown by the respective
PMFs over the duration of the experiment.
The experimental data in ﬁgure 3 is recast to the
equivalent cumulative distribution function (CDF) form in
ﬁgure 4; classiﬁcation of curve colours/markers is preserved,
i.e. the CDFs in ﬁgure 4(a), F x( )M and F x( ),E correspond to
Table 1. Empirical values of experimental and ISDD parameters.
NP CdTe
NP Concentration (nMol), Nc 10
Major Axis Length (nm)a 10
Packing fraction ( −nm 2)a 0.02
Fractal dimensionb 2.3
Area of ﬂask, A f (m2) × −75 10 4
Media volume (mL), VM 2
Media depth μm( ) 287
a
Hondow et al [11].
b
Estimated as +d 1f (see Falconer [31], chapter
6), where d f is the fractal dimension of the 2d
projection of the actual 3d NP aggregate, i.e.
TEM image.
Figure 2. Simulated transport properties of CdTe NP agglomerate
generated by the ISDD model. The solid black line is the mean
transport rate of agglomerate to the cell surface, γ x( ). The curves
associated with the blue ‘x’ and green circle markers indicate the
individual diffusion and sedimentation rates respectively. The
dominant transport mechanism switches from diffusion to sedi-
mentation for >x 100 NPs. The minimum of γ x( ) at x ~ 100 NPs
suggests agglomerates around this size are transported least rapidly
to the cell surface.
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that generated from experimental measurements of NP
agglomerates in cell culture media and within endosome
compartments respectively. In alignment with that measured
experimentally, we evaluate equation (5) for 500 trials and
estimate the number of NPs per endosome NE for each trial.
From this data we can calculate F x( ),ENHPP an in silico pre-
dicted CDF via the NHPP. F x( )ENHPP is also displayed in
ﬁgure 4(a) as the blue curve with ‘x’ markers. A statistical
assessment of F x( )ENHPP and F x( )E through application of a
two-sample Kolmogorov–Smirnov test does not reject the
null hypothesis at a signiﬁcance level of 1% (p-value of
0.999 ), suggesting that both distributions are equivalent. The
accuracy of ﬁt between F x( )ENHPP and F x( )E was iteratively
achieved through optimization of the magnitude of the mean
lifetime of an EAD, τ, the models only ﬁtting parameter.
Throughout the optimization process the mean EAD radii RE
was ﬁxed at 213 nm (sample mean of the 500 TEM images),
this magnitude is comparable to that of clathrin-coated pits
Figure 3. (a) PMFs of the number of constituent nanoparticles measured per cluster in media and within endosome compartments 1 h post
nanoparticle load, black and red curves (circle/square markers) respectively. 500 clusters for each situation were examined to generate the
PDFs. (b) and (c) TEM images of two typical NP clusters containing 1 and 51 individual NPs respectively; both images were measured in the
media surrounding the cellular population. Figures (d) and (e) display TEM images of two endosomes containing NP clusters, the total NP
load in the ﬁrst is 17 NPs and 320 NPs in the second. Bright ﬁeld TEM image contrast has been inverted such that NPs give white contrast
and their identiﬁcation by the image analysis script is shown as red dots. The scale bar for image (b) is 60 nm, for image (c) is 75 nm, for
image (d) and (e) is 100 nm.
Figure 4. Comparison of the CDFs associated with the number of NPs per agglomerate measured experimentally and that predicted via the
NHPP. (a) The black curve with circle markers and the red curve with square markers are the CDFs of the measured data at 0 h in media and
1 h post NP load within endosome compartments respectively (i.e. F x( )M and F x( ) ).E The blue curve with ‘x’ markers is the optimized CDF
predicted by the NHPP methodology, F x( );ENHPP the mean lifetime of the EAD was determined to be τ = 63 s when =R 213 nm.E A two-
sample Kolmogorov–Smirnov test on F x( )E and F x( )ENHPP does not reject the null hypothesis at a signiﬁcance level of 1% (p-value of 0.999 ).
(b) The data points (circle markers) show the PMF associated with the predicted number NP agglomerates per EAD. The PMF is from 500
simulated EADs using the optimized value of τ and the sample average endosome radii. The data is ﬁtted by the Poisson distribution (black
dashed line) which predicts that a mean number of ~3 NP agglomerates in media combine to form larger aggregates measured within the
endosome. (c) Here the data points (circle markers) indicate the PMF associated with the number of NPs per agglomerate that will merge
across the endosome population.
6
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measured through stochastic optical reconstruction micro-
scopy [30]. Location of the optimized lifetime value τ was
established through numerical minimization of the L2-norm of
F x( )ENHPP and F x( ).E Thus the optimized mean lifetime of an
EAD was found to be 63 s, corresponding favourably to the
lifetimes measured directly through high-resolution micro-
scopy techniques [27, 28].
At the optimized value of τ and RE ﬁxed at 213 nm, we
calculate the PMF associated with the number of constituent
NP agglomerates per EAD, N x( ), over the 500 trials. The
PMF of N x( ), P N x( ( )), is displayed in ﬁgure 4(b) (circle
markers) also shown by the black dashed line is a Poisson
distribution ﬁt to the calculated data (p-value—0.001). The
mean rate λ =N x( ( ( )) 3.05) of the Poisson distribution
indicates that ~3 distinct NP agglomerates merge within the
lifetime of the EAD to form a larger internalized aggregate.
Figure 4(c) is the PMF of the NP agglomerates that will
undergo fusion in order to optimize best ﬁt of the in-silico
endosome population.
The main features of ﬁgure 4(c) indicate that the most
probable NP agglomerates that undergo a fusion event are
those containing 10–20 NPs, and those containing
300–400 NPs, additionally there is a low probability that
agglomerates containing ~100 NPs will merge and zero
probability of individual agglomerates >800 as they have not
been detected experimentally, so are not sampled. These
features approximately reﬂect the mean rate of transport of the
NP agglomerates to the EADs generated by the ISDD model
(see materials and methods—ISDD ﬁgure 2). The ISDD
predicts high rates of transport to the cell surface for small
(<10 NPs) and large (>300 NPs) agglomerates via diffusion
and sedimentation respectively and a relatively slow transport
of agglomerates that contain approximately 100 NPs. Thus,
on average combinations of such NP agglomerates provides
the mechanism that translates P x( )M to P x( ).E The ISDD
model also suggests relatively low numbers of 100 NP
agglomerates in the internalized dose, however, even though
there is a relative drop in probability at this size (see
ﬁgure 3(a)) it is not expected to be signiﬁcant as there is a
strong likelihood that agglomerates of this magnitude can be
created via the high probabilities associated with agglomer-
ates of size 10–50 NPs combining.
Although the actual biological spatiotemporal location of
the amalgamation events cannot be determined, the fact that
we can statistically acknowledge their average occurrence and
dispersion indicates speciﬁc properties of the cell-line/NP
system. In particular, the PMF provides unresolved experi-
mental information of how NP agglomerate dosage is trans-
formed through endocytosis, one of the key factors limiting
the development of nanomedicine based therapeutics and
technologies.
To test the sensitivity of our methodology we investi-
gated how the solution, i.e. F x( ),ENHPP varied if we (i) ﬁxed the
mean lifetime of the EAD at its previously optimized value of
63 s and varied the magnitude of RE contiguously from 62 to
497 nm (the extremities of the experimentally measured
range) and (ii) holding RE ﬁxed at 213 nm and varying τ over
the interval [30, 300] seconds. For every iteration, 500 trials
of equation (5) (reﬂecting the 500 measured endosomes) and
the corresponding CDF (F x( ))ENHPP is deduced. After each in-
silico experiment the mean and standard deviations of the
respective CDF series is calculated, additionally the mean
number of fusion events that have occurred for all iterations
of the CDFs series is calculated and found to be ~3 in both
cases. The means (dashed black lines) and standard deviations
(grey areas) associated with the variation of RE and τ are
displayed in ﬁgures 5(a) and (b) respectively. For reference
both F x( )M and F x( )E are also indicated on both ﬁgures,
black line circles markers and red line square markers
respectively.
The variation of RE corresponds physically to variation
of the capture area associated with EADs; reduction of RE
Figure 5. Sensitivity analysis of model (a) the magnitude of grey shaded area is± one standard deviation of the mean value of F x( )ENHPP when
we let RE range over the interval [62, 497] nm whilst τ remains ﬁxed at its optimum value (63 s). (b) The magnitude of grey shaded area is ±
one standard deviation the mean value of F x( )ENHPP when RE is ﬁxed at the sample average (213 nm) and the magnitude of the lifetime
associated with an EAD varies over the range [30, 240] seconds.
7
Nanotechnology 26 (2015) 155101 M R Brown et al
vastly increases the variability of predicted F x( ) especially
for aggregates having <x 100 corresponding to the diffusion
dominated transport regime. For >x 100, F x( ) does not
deviate substantially from the optimum CDF shown in
ﬁgure 4(a) suggesting that at least one of the three fusion
events likely to occur is between relatively large agglomer-
ates. As the magnitude of RE increases in size past the sample
mean the calculated CDFs are shifted positively in x. This is
unsurprising as (i) equation (6) indicates that the number of
agglomerates at the EAD will increase proportionally to the
magnitude of R ,E and (ii) a large proportion of these
agglomerates will be that driven by sedimentation as this on
average is the dominant transport mechanism an is associated
with the larger NP agglomerates. Figure 5(b) illustrates the
variability of F x( ) when the lifetime of the EAD is varied
from half its optimized value to that ﬁve times greater than its
optimized value and the capture area of the EAD is ﬁxed at
~0.014 μm2. The general features of the variability follow that
observed for RE variation, i.e. larger ﬂuctuation in F x( ) for
<x 100 for small EAD lifetimes, and a positive shift in
magnitude of F x( ) as the lifetime is increased well beyond
the optimized value of 63 s. In an analogous manner to that
previously described, this shift is not surprising as we are
again increasing the possibility of larger agglomerate fusion
events as they have the dominant transport mechanism in
these simulations.
The generally low dispersion observed for F x( ) (for
>x 100 NPs) is interesting and suggests that the net NP
aggregation by endosomes is insensitive to both the magni-
tude of the EAD and its mean lifetime. The former feature
reﬂects TEM measurements that indicate small NP agglom-
erates are found within much larger endosome compartments
and equally many large NP agglomerates are found within
similar sized compartments (e.g. ﬁgures 3(d) and (e)).
Ongoing and future experiments will quantify this feature
further. The larger ﬂuctuations of F x( ) for small x, in both
cases, is related to increased sampling variability and will
have a major impact on the predictability of dosage when no
agglomeration is present, i.e. for monodispersions of NPs.
Discussion
This study directly addresses key factors limiting the devel-
opment of nanomedicine based therapeutics; we precisely
quantify actual NP dosage as opposed to that perceived, in
doing so we encapsulate the innate heterogeneity of the
nanotheraputic state. We provide a robust methodology that
allows the trafﬁcking of NP dosage across biological barriers
to be understood quantitatively which provides the basis for
predictive modelling of nanopharmacology. In this study, we
have focused on quantifying biological barrier trafﬁcking of
Qtracker 705 quantum dots exposed to U-2 OS cells in
McCoy’s 5a medium media.
The methodology couples high spatial resolution TEM
with pertinent physical models that together are statistically
sampled to infer the dynamical properties of a NP dose.
Speciﬁcally, through TEM measurements [11] we
characterize the aggregating properties associated with NP
agglomerates at two distinct spatiotemporal biological posi-
tions (i) in biological media and (ii) within cellular endosome
compartments in human osteosarcoma cells [15, 17, 19–
21, 23, 24]. The statistical proﬁle of NP dose at these distinct
spatiotemporal positions was captured by PMFs that sum-
marize the properties of 500 quantum dot NP agglomerates,
which describe the heterogeneity of particle number within
measured agglomerates. We detailed and developed a sto-
chastic transfer function (STF) that permits evolution of states
from P x( )M to P x( ).E The STF has two principal compo-
nents, ﬁrstly the previously reported ISDD model [26] is
embedded to provide a mean rate of NP agglomerate transport
to the cell surface and (ii) system heterogeneity simulated
through application of a nonhomogeneous Poisson distribu-
tion, which stochastically determines agglomerate arrival at
the cell surface where it may be part of and endocytic event
and subsequently internalized by a cell. The STF’s principal
ﬁtting parameter reﬂects the lifetime of an endocytic event, its
optimized magnitude was found to be commensurate with
direct measurements of clathrin-coated pits through high-
resolution microscopy techniques [27, 28]. Further analysis of
the STF provides previously unresolved dynamics of the NP
agglomerate traverse across the cell membrane, quantifying
statistically agglomerates fusion as NP dose is translated from
cell-culture media to endosome vesicles. Through optimiza-
tion and sampling of the statistical methodology we are
conﬁdent in stating that the heterogeneity of the internalized
NP dose (reported previously [15, 24]) is a result of the initial,
inhomogeneous dispersion of the NPs in the cell culture
media used for particle exposure.
This manuscript has developed a statistical framework
for the detection (by TEM), quantiﬁcation and prediction of
quantum dots dispersed in media and following uptake by any
cells all at the scale of the individual quantum dot. Future
work will examine and assess how speciﬁc variables of the
system, e.g. cell/NP type, NP surface coating, concentration
or applied exposure dose of NPs have on the heterogeneity
measured at both temporal locations and how these are sta-
tistically translated across the biological membrane. Addi-
tionally, we will combine the methods presented here with
that previously developed [15] to fundamentally link high-
throughput ﬂow cytometry measurements with TEM based
statistics to provide accurate assessment of actual NP dosage
and its evolution and redistribution across a large cellular
population over signiﬁcant periods.
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